MoneyWorks4Me

Nectar Lifesciences informs about post buyback public announcement

16 Jan 2026 Evaluate
Nectar Lifesciences has informed that Master Capital Services (Manager to the Buyback) has submitted a copy of Post Buyback Public Announcement for the attention of equity shareholders / beneficial owners of equity shares of Nectar Lifesciences (the Company).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.55
Dr. Reddys Labs. 1319.00
Cipla 1367.70
Lupin 1957.60
Zydus Lifesciences 1170.90
View more..